(Reuters) -AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira in a head-to-head trial. The study tested the two drugs in 492 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback